Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global Intravenous Solutions Market, valued at approximately US$14 billion in 2024, is anticipated to witness significant growth, reaching a projected valuation of nearly US$32 billion by the end of 2031. The demand for intravenous solutions is expected to surge due to the sedentary lifestyle affecting around 39% of the world's population, particularly among the aging demographic facing chronic conditions like cancer, heart disease, stroke, diabetes, and arthritis.

Intravenous solutions play a crucial role in providing necessary nutrients to patients in Intensive Care Units (ICUs), with higher efficacy linked to quicker response times. The market's expansion is significantly contributed to by therapy with intravenous solutions.

Key Drivers for the Intravenous Solutions Market:

Severe Dehydration Treatment: Intravenous (IV) fluids play a pivotal role in treating severe dehydration, particularly resulting from diseases like diarrhea, which deplete the body's fluid reserves. According to the World Health Organization (WHO), in 2017, diarrhea accounted for approximately 525 thousand annual deaths among children under five years old, making it the second leading cause of mortality in this age group. IV fluids prove extremely helpful in averting fatalities induced by disease-related dehydration and fluid loss.

Premature Births: The incidence of premature births has been steadily increasing, with one in ten babies born in the nation in 2019 experiencing premature birth. IV solutions, rich in proteins, calories, and electrolytes, are anticipated to witness a surge in demand alongside the rising occurrence of preterm births.

Cost Savings: Standard intravenous solutions offer cost savings attributed to a reduction in administering supplies and nursing time. While normal (0.9%) saline is generally less expensive than other fluid preparations, the cost of intravenous fluid varies significantly between fluid types and nations. Notably, the use of a common intravenous solution administering process, compared to a 2-in-1 plus a separate IVFE injection, reduces nursing time by half (2.2 vs. 4.3 hours).

Market Outlook for 2024 to 2031:

The Intravenous Solutions Market is poised for robust growth in the coming decade, driven by the aforementioned key drivers. The demand for IV therapy is expected to remain strong, with the United States leading the market as the largest consumer, presenting a substantial absolute dollar opportunity.

In conclusion, the sales analysis underscores the critical role of Intravenous Solutions in healthcare, addressing conditions such as severe dehydration and premature births. As the market continues to expand, the emphasis on cost savings and the growing need for IV therapy indicate a positive outlook for the Intravenous Solutions Market in the years ahead.

Key Impact Points:

Increased Demand during the Pandemic: The imperative need for intravenous solutions became more pronounced as COVID-19 patients flooded ICUs globally. The ability of intravenous fluids to provide crucial nutrients to patients on ventilators contributed to their heightened demand.

WHO Recommendations: The World Health Organization underscored the significance of intravenous fluids, particularly for patients experiencing respiratory failure. The recommendation added further impetus to the utilization of intravenous solutions in the management of COVID-19 cases.

Strain on Critical Care Facilities: Critical care wards operating at full capacity in England in January 2021 highlighted the strain on healthcare facilities during the peak of the pandemic. The demand for intravenous fluids was a crucial component in managing patients, especially the older demographic, who faced challenges in oral food intake due to ventilation.

Anticipated Future Trends:

The surge in demand for intravenous solutions during the COVID-19 pandemic is expected to have a lasting impact, with an anticipation of continued growth in the coming years. As the healthcare sector adapts to evolving challenges, the importance of intravenous fluids in critical care scenarios is likely to remain high.

In conclusion, the COVID-19 pandemic has underscored the indispensable role of intravenous solutions in the treatment and care of critically ill patients. The increased demand witnessed during the pandemic is expected to shape future trends, emphasizing the ongoing importance of intravenous solutions in global healthcare.

Region-wise Insights:

The Asia Pacific Intravenous Solutions Market is expected to witness substantial growth, driven by a projected high CAGR. China and India contribute significantly to preterm births globally, with premature infants facing greater risks of growth issues and illnesses. As a result, early parenteral nutrition with adequate energy and amino acids is expected to be a key factor driving the market in the Asia Pacific region.

Country-wise Insights:

U.S. Intravenous Solutions Market Analysis: The United States is poised to offer significant growth opportunities in the Intravenous Solutions Market. The market is projected to experience robust growth from 2024 to 2031, driven by an increased demand for IV medications due to the prevalence of influenza cases.

U.K. Intravenous Solutions Market Analysis: The Intravenous Solutions Market in the United Kingdom is expected to grow steadily during the forecast period, with a substantial absolute dollar opportunity. By 2031, the market is anticipated to reach a noteworthy valuation, driven by consistent growth between 2024 and 2031.

Japan Intravenous Solutions Market Analysis: In Japan, the Intravenous Solutions Market is set to expand and reach a considerable size by 2031, with an absolute dollar opportunity during the forecast period. The market is expected to achieve steady growth in this timeframe.

South Korea Intravenous Solutions Market Analysis: The Intravenous Solutions Market in South Korea is expected to present notable opportunities, with a growth trajectory between 2024 and 2031. The market is projected to achieve a significant size during this period.

Competitive Analysis:

Key players in the Intravenous Solutions Market, including:

Key Companies Profiled

• Fresenius Kabi
• Sino-Swed Pharmaceutical Corp., Ltd
• Hospira
• Amanta Healthcare
• Otsuka Pharmaceutical Co., Ltd
• Sichuan Kelun Pharmaceutical Co., Ltd
• Terumo Corporation
• Baxter
• B. Braun Melsungen AG
• Claris Lifesciences Ltd
• Kyowa Hakko Bio Co., Ltd
• Grifols
• Liqvor Pharmaceuticals

Key Segments Covered in Intravenous Solutions Market Survey

By Type:

• Total Parenteral Nutrition (TPN)
• Peripheral Parenteral Nutrition (PPN)

By Nutrients:

• Carbohydrates
• Single Dose Amino Acid Solution
• Vitamins & Minerals (Salt and Electrolyte)
• Parenteral Lipid Emulsion
• Other Nutrients

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

This product will be delivered within 1-3 business days.